IDAAPM: integrated database of ADMET and adverse effects of predictive modeling based on FDA approved drug data



IDA2PM is a integrated database for ADMET and adverse effects based on FDA approved drug data, which have been developed as a useful resource for computational analyses and modelling. IDA2PM aims to bridge the gap by providing in a single resource, integrated detailed information on approved drugs such as structures, molecular descriptors, ADMET and adverse effects properties, target and also related bioactivity.
Datum som det gjorts tillgängligt2017
FörlagJournal of cheminformatics
Datum för dataproduktion2016

Citera det här